TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
This Quarter Return
+16.47%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$1.4B
AUM Growth
+$1.4B
(+43%)
Cap. Flow
+$313M
Cap. Flow
% of AUM
22.32%
Top 10 Holdings %
Top 10 Hldgs %
35.88%
Holding
163
New
35
Increased
43
Reduced
14
Closed
8
Top Buys
| 1 |
Aurinia Pharmaceuticals
AUPH
|
$32.6M |
| 2 |
BioNTech
BNTX
|
$32.1M |
| 3 |
Relay Therapeutics
RLAY
|
$25.3M |
| 4 |
ITOS
iTeos Therapeutics
ITOS
|
$24.6M |
| 5 |
Immunocore
IMCR
|
$21.8M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$24.4M |
| 2 |
Dynavax Technologies
DVAX
|
$6.68M |
| 3 |
Beam Therapeutics
BEAM
|
$2.45M |
| 4 |
Inhibrx
INBX
|
$2.37M |
| 5 |
CRISPR Therapeutics
CRSP
|
$2.35M |
Sector Composition
| 1 | Healthcare | 95.59% |
| 2 | Technology | 1.47% |
| 3 | Communication Services | 1.22% |
| 4 | Real Estate | 0.34% |
| 5 | Financials | 0.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Kiniksa Pharmaceuticals
KNSA
$2.63B
| $15.7M | 1.12% |
628,609
+3,300
| +0.5% | +$82.5K |
|
27
Jazz Pharmaceuticals
JAZZ
$7.99B
| $15.6M | 1.11% |
140,000
| – | – |
|
28
Atea Pharmaceuticals
AVIR
$275M
| $15.4M | 1.1% |
4,607,060
+130,319
| +3% | +$437K |
|
29
Cullinan Oncology
CGEM
$456M
| $15.4M | 1.1% |
921,138
| – | – |
|
30
Meta Platforms (Facebook)
META
$1.85T
| $14.8M | 1.06% |
25,855
+14,459
| +127% | +$8.28M |
|
31
Rocket Pharmaceuticals
RCKT
$358M
| $13.9M | 0.99% |
750,000
| – | – |
|
32
Zymeworks
ZYME
$1.07B
| $13.8M | 0.99% |
1,100,000
| – | – |
|
33
Replimune Group
REPL
$460M
| $13.2M | 0.94% |
1,200,000
+394,560
| +49% | +$4.32M |
|
|
RVNC
34
DELISTED
Revance Therapeutics, Inc.
RVNC
| $13M | 0.93% |
2,500,000
+2,100,000
| +525% | +$10.9M |
|
|
CRGX
35
DELISTED
CARGO Therapeutics
CRGX
| $12.9M | 0.92% |
700,749
+128,052
| +22% | +$2.36M |
|
36
Teladoc Health
TDOC
$1.37B
| $12.9M | 0.92% |
1,400,000
+400,000
| +40% | +$3.67M |
|
37
Novavax
NVAX
$1.2B
| $12.6M | 0.9% |
+1,000,000
| New | +$12.6M |
|
|
38
CRISPR Therapeutics
CRSP
$4.82B
| $12.5M | 0.89% |
266,500
-50,000
| -16% | -$2.35M |
|
39
Corbus Pharmaceuticals
CRBP
$121M
| $12.4M | 0.88% |
+600,000
| New | +$12.4M |
|
40
Adicet Bio
ACET
$60.8M
| $11.8M | 0.85% |
8,216,960
| – | – |
|
41
AstraZeneca
AZN
$255B
| $11.7M | 0.83% |
150,000
| – | – |
|
42
Harmony Biosciences
HRMY
$2.16B
| $11.2M | 0.8% |
281,200
| – | – |
|
43
Vanda Pharmaceuticals
VNDA
$279M
| $11M | 0.79% |
2,353,307
+200,000
| +9% | +$938K |
|
44
Immunome
IMNM
$892M
| $10.5M | 0.75% |
720,000
| – | – |
|
45
CytomX Therapeutics
CTMX
$350M
| $9.22M | 0.66% |
7,811,760
+19,824
| +0.3% | +$23.4K |
|
46
Nuvation Bio
NUVB
$1.08B
| $8.93M | 0.64% |
3,900,000
+148,136
| +4% | +$339K |
|
47
Elanco Animal Health
ELAN
$8.62B
| $8.81M | 0.63% |
+600,000
| New | +$8.81M |
|
48
HilleVax
HLVX
$105M
| $8.66M | 0.62% |
+4,920,000
| New | +$8.66M |
|
49
Outlook Therapeutics
OTLK
$39.5M
| $8.33M | 0.59% |
1,559,560
-59,852
| -4% | -$320K |
|
|
ONC
50
BeOne Medicines Ltd. American Depositary Shares
ONC
$37B
| $8.31M | 0.59% |
37,000
| – | – |
|